NAFDAC has blacklisted India-based Aveo Pharmaceuticals and banned its opioid drugs, Tafrodol and Royal 225, over safety concerns. The agency warns against the illegal sale of unregistered medications, linking the company to drug abuse in West Africa. Authorities vow stricter enforcement to...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.